Sharescart Research Club logo
Apollo Green 64 (-3%)Care Health 118 (-7.8%)Cheelizza Pizza 26 (0%)CSK 265 (-15.1%)Ecosure Pulpmolding 42 (0%)ESDS Software 388 (0.8%)Goa Shipyard 2950 (-3.3%)Goodluck Defence 312 (1.3%)HDFC Securities 9000 (0%)Hella Infra 117500 (0%)Hero Fincorp 1050 (0%)HPX India 26 (0%)Matrix Gas 18 (-10%)Motilal Oswal 11.5 (-1.7%)MSEI 5.6 (13.1%)Nayara Energy 1200 (-7.7%)Nnt Developers 85 (0%)NSE 1898 (-2.9%)Onix Renewable 58 (-14.7%)Orbis Financial 415 (0%)OYO 23 (0%)OYO Assets 28 (12%)PolicyX 62 (6.9%)Polymatech Electronics 64 (-3%)Ramaraju Surgical 285 (0%)RRP S4E 218 (-3.1%)SBI Mutual 775 (0%)

15 Days Price Change

Gaudium IVF & Women IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 115.5 Cr
Profile
Price Range 75  to  79 per share
Profile
Min Investment ₹79
Profile
Lot Size 1
Profile
Face Value ₹5
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Parenthood is a joyful journey, especially for mothers who experiences motherhood. We understand the challengescouples face in building a family due to infertility, medical issues, or lifestyle factors. Our mission is to help maketheir dream of parenthood come true through personalized fertility treatments. From the first consultation to asuccessful pregnancy, we provide expert care, support, and a close partnership with our patients, ensuring a hopefuland joyful future. Read More

Basic Info

Face Value 5 per share

Price 75  to  79 per share

P/E (x) 25.5

Sales( Cr.) 71

PAT( Cr.) 19

EPS 3.1

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Manika Khanna Peeyush Khanna Vishad Khanna

Pre Issue Share Holding 99.98%

Post Issue Share Holding 71.29%

Listing Details:

Listing Price: 83

Listing Gain: 4.82%

Current Price: 76.5

Gain On Issue: 76.5 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Feb 20, 2026
Closing Date Feb 24, 2026
Allotment Feb 25, 2026
Refund Feb 26, 2026
Delivery of Shares Feb 26, 2026
Listing Date Feb 27, 2026

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 189 14,931
Retail (Max) 13 2457 194,103
S-HNI (Min) 14 2646 209,034
S-HNI (Max) 66 12474 985,446
B-HNI (Min) 67 12663 1,000,377

Objective of the Issue

1) Funding capital expenditure towards establishment of New IVF Centers of our Company.2) Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company.3) General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 4177240 6785478 1.6x
NII 3132930 44022069 14.1x
Retail 7310170 55542942 7.6x
EMP 0 0 0x
Total 14620340 106350489 7.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Gaudium IVF & Women Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 37 44 48 71
Other Income 0 0 0 0
Total Income 37 44 48 71
Total Expenditure 23 24 28 42
Operating Profit 14 20 20 29
Interest 1 0 1 2
Depreciation 1 1 2 2
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 12 18 17 25
Provision for Tax 3 5 6 6
Profit After Tax 9 14 10 19
Adjustments 0 0 0 0
Profit After Adjustments 9 14 10 19
Adjusted Earnings Per Share 1.4 2.2 1.7 3.1

Gaudium IVF & Women Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 9 23 27 46
Minority's Interest 0 0 0 0
Borrowings 2 2 2 2
Other Non-Current Liabilities 0 2 2 2
Total Current Liabilities 6 10 20 38
Total Liabilities 18 37 51 89
Fixed Assets 4 18 19 18
Other Non-Current Assets 0 0 3 17
Total Current Assets 14 18 30 54
Total Assets 18 37 51 89

Gaudium IVF & Women Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 15 12
Cash Flow from Operating Activities -1 24 3 9
Cash Flow from Investing Activities -1 -16 -5 -15
Cash Flow from Financing Activities 3 5 -1 2
Net Cash Inflow / Outflow 0 13 -3 -5
Closing Cash & Cash Equivalent 2 15 12 7

Gaudium IVF & Women Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.44 2.2 1.68 3.12
CEPS(Rs) 1.6 2.44 2.03 3.45
DPS(Rs) 0 1.03 0 0
Book NAV/Share(Rs) 1.51 3.7 4.4 7.54
Core EBITDA Margin(%) 37.04 45.69 40.59 40.83
EBIT Margin(%) 34.39 42.5 36.63 38.27
Pre Tax Margin(%) 32.86 41.4 34.73 35.95
PAT Margin (%) 24.17 30.57 21.54 27.05
Cash Profit Margin (%) 26.83 33.82 26.05 29.94
ROA(%) 50.27 49.92 23.55 27.42
ROE(%) 94.99 84.47 41.5 52.2
ROCE(%) 82.39 78.74 46.65 50.15
Receivable days 64.91 30.54 55.26 119.89
Inventory Days 3.35 7.57 13.73 24.08
Payable days 114.13 87.5 72.31 178.13
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.15 -0.1 0.1 0.6
EV/Core EBITDA(x) 0.4 -0.21 0.25 1.46
Net Sales Growth(%) 0 21.13 8.26 47.68
EBIT Growth(%) 0 49.7 -6.68 54.28
PAT Growth(%) 0 53.21 -23.72 85.4
EPS Growth(%) 0 53.21 -23.72 85.39
Debt/Equity(x) 0.64 0.43 0.58 0.41
Current Ratio(x) 2.29 1.92 1.5 1.42
Quick Ratio(x) 2.23 1.76 1.39 1.23
Interest Cover(x) 22.44 38.53 19.23 16.46
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 48% 24% 0% 0%
Operating Profit CAGR 45% 27% 0% 0%
PAT CAGR 90% 28% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 52% 59% 68% 68%
ROCE Average 50% 59% 64% 64%

Company Contact Information

Gaudium IVF and Women Health Ltd.

Naveen Kumar

011- 4885 8585

compliance@gaudiumivfcentre.com

B1/51, Janakpuri B-1

IPO Lead Manager(s)

Gaudium IVF and Women Health Ltd.

Sarthi Capital Advisors Pvt Ltd.

Registrar Info

Gaudium IVF and Women Health Ltd.

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093 (old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059 Tel: + 91 21 626 38200 Fax:

91-022-62638200

91-022-62638299

Investor@bigshareonline.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp